Although the study was prospective in nature, it had several methodological limitations including small sample size, selective sample, and use of alanine aminotransferase (ALT), hepatic steatosis index (HSI), and fatty liver index (FLI) as surrogates of NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.